Back
Corvus Pharmaceuticals, Inc. Stock Price Chart
Coinbase Lost $400M. Your Crypto Isn't Safe on Exchanges.
Stop trusting exchanges. Learn how to access Native Markets where YOU control your assets
Buy
65
CRVS
Corvus Pharmaceuticals, Inc.
Last Price:
$25.66
Seasonality Move:
-18%
7 Day Trial
ALL ACCESS PASS
$
7
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CRVS is experiencing slight buying pressure.
Corvus Pharmaceuticals, Inc. Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 13.04 | Buy |
| 20-day SMA: | 9.59 | Buy |
| 50-day SMA: | 8.9 | Buy |
| 200-day SMA: | 5.89 | Buy |
| 8-day EMA: | 15.76 | Buy |
| 20-day EMA: | 11.46 | Buy |
| 50-day EMA: | 9.27 | Buy |
| 200-day EMA: | 5.51 | Buy |
Corvus Pharmaceuticals, Inc. Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 2.85 | Buy |
| Relative Strength Index (14 RSI): | 92.93 | Buy |
| Chaikin Money Flow: | 5533196 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.14 - 14.42) | Buy |
| Bollinger Bands (100): | (4.94 - 10.68) | Buy |
Corvus Pharmaceuticals, Inc. Technical Analysis
| Jan 8 | Jan 9 | Jan 12 | Jan 13 | Jan 14 | Jan 15 | Jan 16 | Jan 20 | Jan 21 | Jan 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan | ||||||||||
| 08 | 09 | 12 | 13 | 14 | 15 | 16 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Corvus Pharmaceuticals, Inc. Stock
Is Corvus Pharmaceuticals, Inc. Stock a Buy?
-
Corvus Pharmaceuticals, Inc. share price is 25.52 while CRVS 8-day simple moving average is 13.04, which is a Buy signal.
-
The stock price of CRVS is 25.52 while Corvus Pharmaceuticals, Inc. 20-day SMA is 9.59, which makes it a Buy.
-
Corvus Pharmaceuticals, Inc. 50-day simple moving average is 8.90 while CRVS share price is 25.52, making it a Buy technically.
-
CRVS stock price is 25.52 and Corvus Pharmaceuticals, Inc. 200-day simple moving average is 5.89, creating a Buy signal.
CRVS Technical Analysis vs Fundamental Analysis
Buy
65
Corvus Pharmaceuticals, Inc. (CRVS)
is a Buy
Is Corvus Pharmaceuticals, Inc. a Buy or a Sell?
-
Corvus Pharmaceuticals, Inc. stock is rated a BuyThe current Corvus Pharmaceuticals, Inc. [CRVS] share price is $25.52. The Score for CRVS is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.
Corvus Pharmaceuticals, Inc. Stock Info
Market Cap:
1.9B
Price in USD:
25.52
Share Volume:
12.8M
Corvus Pharmaceuticals, Inc. 52-Week Range
52-Week High:
26.22
52-Week Low:
2.54
Buy
65
Corvus Pharmaceuticals, Inc. (CRVS)
is a Buy
Corvus Pharmaceuticals, Inc. Share Price Forecast
-
What is the Corvus Pharmaceuticals, Inc. stock price today?The Corvus Pharmaceuticals, Inc. stock price is 25.52 USD today.
-
Will CRVS stock go up or go down?Corvus Pharmaceuticals, Inc.> share price is forecast to RISE/FALL based on technical indicators
-
Is Corvus Pharmaceuticals, Inc. overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Corvus Pharmaceuticals, Inc. is not overvalued.
Is Corvus Pharmaceuticals, Inc. Stock a Buy?
-
Corvus Pharmaceuticals, Inc. share price is 25.52 while CRVS 8-day exponential moving average is 15.76, which is a Buy signal.
-
The stock price of CRVS is 25.52 while Corvus Pharmaceuticals, Inc. 20-day EMA is 11.46, which makes it a Buy.
-
Corvus Pharmaceuticals, Inc. 50-day exponential moving average is 9.27 while CRVS share price is 25.52, making it a Buy technically.
-
CRVS stock price is 25.52 and Corvus Pharmaceuticals, Inc. 200-day simple moving average is 5.51, creating a Buy signal.
Fundamental Analysis of Corvus Pharmaceuticals, Inc.
Is Corvus Pharmaceuticals, Inc. a good investment?
-
Analysts estimate an earnings decrease this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.42 per share, and a decrease next year of $0.03 per share.
Technical Analysis of Corvus Pharmaceuticals, Inc.
Should I short Corvus Pharmaceuticals, Inc. stock?
-
CRVS Moving Average Covergence Divergence (MACD) indicator is 2.85, suggesting Corvus Pharmaceuticals, Inc. is a Buy
-
Corvus Pharmaceuticals, Inc. Relative Strength Index (RSI) is 92.93, which suggest Corvus Pharmaceuticals, Inc. is overbought
-
The Bollinger Bands (25) for Corvus Pharmaceuticals, Inc. is (4.14 - 14.42), which suggest Corvus Pharmaceuticals, Inc. is a Buy
-
The Bollinger Bands (100) for Corvus Pharmaceuticals, Inc. is (4.94 - 10.68), which suggest Corvus Pharmaceuticals, Inc. is a Buy
* Corvus Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.